Revolution Medicines
The Director, Pipeline & Product Communications leads the strategy and execution of communications for one or more RAS(ON) inhibitors or tumor types, shaping scientific narratives for external stakeholders including medical audiences, patients, and media. The role partners with cross‑functional teams such as R&D, Medical Affairs, Regulatory, Commercial, Market Access, Patient Advocacy, Legal, and Corporate Communications to ensure clear, consistent, and differentiated messaging throughout clinical development, regulatory milestones, and pre‑launch activities.
Headquarters
Redwood City, California, United States
Company Size
201-500 employees
Founded
2014
Revolution Medicines (RevMed) is a biopharmaceutical company dedicated to discovering, developing, and delivering novel targeted medicines for patients with cancer. Their mission focuses specifically on "revolutionizing treatment for patients with RAS‑addicted cancers" through precision-targeted therapies. The company emphasizes a science-driven, end-to-end approach from discovery to delivery. RevMed brands its team as "Revolutionaries" committed to transforming outcomes for people with RAS‑driven tumors.
Victory Capital Management Inc. Trims Stock Holdings in Revolution Medicines, Inc. $RVMD
13 hours ago
Revolution Medicines Trials, Funding Capacity And Insider Moves Shape Risk Outlook
5 days ago
Revolution Medicines Reports Fourth Quarter and Full Year 2025 Financial Results and Update on Corporate Progress
2 weeks ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Revolution Medicines.
28% above the average for this role
Revolution Medicines, Inc. (RVMD) Net Loss Widens amid Progress on Clinical Trial Programs
1 week ago
Scientific Communications Leader
BioNTech
Director R&D & Early Pipeline Communications
AstraZeneca
Director, Scientific Communications
kaileratherapeutics
Senior Communications Consultant
IFM Investors
Director, Product Communications
Compass Pathways
Associate Scientific Director - Medical Communications
Avalere Health